GE HealthCare and Medis Medical Imaging Announce Collaboration focused on Non-Invasive Coronary Assessments to Help Advance Precision Care in Treatment of Coronary Artery Disease 

Today, GE HealthCare (Nasdaq: GEHC), a leading global medical technology, pharmaceutical diagnostics and digital solutions innovator, and Medis Medical Imaging, a leading cardiac imaging software company, announced their collaboration aimed at helping advance precision care in the diagnosis and treatment of coronary artery disease (CAD).

Read More

All good things come in 3.0: the release of Medis QFR® 3.0

We are excited to officially announce the launch of Medis QFR® 3.0, our latest solution designed to streamline your Cath lab workflow for physiology and morphology assessments of intermediate coronary lesions. This new version will bring innovative features, accessibility from anywhere within the hospital network, and a completely new look & feel.

Read More

Join the hands-on workshops to explore Medis QFR® 3.0 at the Training Village at EuroPCR 2024.

Clinical experts will share their experiences with Medis QFR® 3.0 through a combination of presentations and hands-on sessions, and you could interact with them in a friendly and open environment. Be ready to learn how they successfully implemented Medis QFR®, to reach the expected clinical outcomes for better patient care.

Read More

Discover how QFR transforms diagnostic tools for Epicardial and Microvascular Disease in the Cath Lab

– Learn how the newest QFR technology enables coronary physiology analysis in under 30 seconds.
– Understand the role of QFR-IMR as a diagnostic tool for coronary microvascular dysfunction assessment.
– Learn how QFR paves the way for new horizons in treatment options.

Read More

Post-PCI: QFR independently predicts adverse events after stent implantation

Lower values of QFR after complete and successful revascularization is associated with 3-time increase in the risk of subsequent adverse events

Read More

During-PCI: QFR-guided PCI approach improves long term clinical outcomes

In the FAVOR III China trial, we investigated whether utilizing quantitative flow ratio (QFR) guidance in lesion selection for percutaneous coronary intervention (PCI) could improve clinical outcomes compared to standard angiography guidance.

Read More

The next edition of Medis Tips, Tricks, and Shortcuts is now available!

We introduced this new section to share tips across all product lines. By sharing this, we want to transfer the knowledge we receive from you and all your peers and enable the use of Medis software to its full potential.

Read More

Pre-PCI: QFR helps in PCI planning

QFR-based virtual PCI is superior to conventional angiography-based PCI at achieving optimal post-PCI physiology results without significantly increasing procedural time, contrast due or X-ray use.

Read More

Medis QFR® featured in 2 live presentations at CRT 2024!

Many thanks to Yuhei Kobayashi, MD and Prof. Morton Kern for their illuminating presentations at CRT 2024, highlighting the remarkable advancements with Medis QFR.

Read More

QFR proves to be an effective substitute for invasive physiological assessment, due to a high negative predictive value of 92.3%

Dr. Liontou and co-authors, under the leadership of Dr. K. Triantafyllou of the 1st Cardiology Dept. at Evangelismos General Hospital in Athens, Greece, published this interesting paper in Int. J. Cardiovascular Imaging.

Read More